TAK-700 (Orteronel)
CAS No. 566939-85-3
TAK-700 (Orteronel) ( Orteronel )
Catalog No. M15061 CAS No. 566939-85-3
Orteronel(TAK-700) was selected as a candidate for clinical evaluation.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 688 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTAK-700 (Orteronel)
-
NoteResearch use only, not for human use.
-
Brief DescriptionOrteronel(TAK-700) was selected as a candidate for clinical evaluation.
-
DescriptionOrteronel(TAK-700) was selected as a candidate for clinical evaluation. orteronel (TAK-700) is currently in phase III clinical trials for the treatment of castration-resistant prostate cancer.
-
SynonymsOrteronel
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
Recptor20-lyase(Rat); 20-lyase(Human)
-
Research AreaCancer
-
IndicationProstate Cancer
Chemical Information
-
CAS Number566939-85-3
-
Formula Weight307.35
-
Molecular FormulaCHNO
-
Purity>98%(HPLC)
-
SolubilityDMSO:61 mg/mL (198.47 mM); Ethanol:8 mg/mL (26.02 mM);Water:<1 mg/mL
-
SMILESCNC(=O)C1=CC2=C(C=C1)C=C(C=C2)[C@]3(CCN4C3=CN=C4)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yamaoka M, et al. J Steroid Biochem Mol Biol. 2012, 129(3-5), 115-128.
molnova catalog
related products
-
Tiliroside
Tiliroside shows antioxidant and anti-inflammatory activity, can inhibit neuroinflammation in neurodegenerative disorders.
-
Bazedoxifene HCl
Bazedoxifene HCl is a novel, non-steroidal, indole-based estrogen receptor modulator (SERM) binding to both ERα and ERβ with IC50 of 23 nM and 89 nM, respectively.
-
DMU2139
DMU2139 is a specific CYP1B1 inhibitor (CYP1B1 and CYP1A1 with IC50 of 9 nM and 795 nM, respectively).